Author:
Boitano Laura T.,Roddy Connor,DeCarlo Charles,Mohebali Jahan,Srivastava Sunita D.
Reference11 articles.
1. Direct oral anticoagulant use: a practical guide to common clinical challenges;Chen;J Am Heart Assoc,2020
2. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
3. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials;Ruff;Lancet,2014
4. Allar D. Cardiovascular Business. 2019 [cited 2021]; Available from: https://www.cardiovascularbusiness.com/topics/vascular-endovascular/doacs-overtaking-warfarin-medicaid-patients.
5. Administration UFaD. ANDEXXA (coagulation factor Xa (recombinant), inactivated-zhzo). 2018 [updated 6/28/2019; cited 2021]; Available from: https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/andexxa-coagulation-factor-xa-recombinant-inactivated-zhzo.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Andexanet-alfa/heparin/plasma;Reactions Weekly;2023-04-01